VANCOUVER, Washington — August 28, 2025 — Leads & Copy — CytoDyn Inc. (OTCQB: CYDY) will participate in the H.C. Wainwright 27th Annual Global Investment Conference, held September 8-10, 2025, at the Lotte New York Palace Hotel in New York City.
Robert E. Hoffman, Chief Financial Officer, will present on Wednesday, September 10, at 1:30 p.m. EDT via webcast. He will also be available for one-on-one meetings with registered attendees.
CytoDyn is focused on advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor for cancer, infectious diseases, and autoimmune disorders.
Investor Relations:
CytoDyn Inc.
ir@cytodyn.com
Media Contacts:
Rob Haney, Ph.D., or Ignacio Guerrero-Ros, Ph.D.
Russo Partners, LLC
CytoDyn@russopartnersllc.com
Source: CytoDyn Inc.
